Trends and outcomes of modern staging of solitary plasmacytoma of bone
Authors:
Open Access
- 14 March 2012
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 87 (7) , 647-651
Abstract
Over the years, the definition of solitary plasmacytoma of bone (SPB) has shifted in part due to more modern testing capabilities. We hypothesized that outcomes data based on antiquated testing would not reflect outcomes using modern staging. To address both how widely applied adequate diagnostic staging is and what the progression rates of SPB as defined with state‐of‐the‐art staging are, we performed a retrospective chart review of those patients with a diagnosis of SPB seen at our institution over the past decade. Two groups were studied: all patients with SPB (n = 127); and those patients referred to our institution for an indication other than progression (n = 91). The median PFS for those two groups were 26 months and 42 months, respectively. At baseline, only a minority of patients had state‐of‐the‐art staging. The 5 patients with both modern imaging and a negative bone marrow had a 21 month PFS of 100%. Patients with plasmacytoma plus, one plasmacytoma but bone marrow consistent with monoclonal gammopathy of undetermined significance, fare worse than true SPB. The use of modern testing is imperative to characterize a patient's risk for progression. PET/CT plays an important role in the diagnostic work‐up. Am. J. Hematol. 87:647–651, 2012.Keywords
This publication has 19 references indexed in Scilit:
- Advances in Imaging and the Management of Myeloma Bone DiseaseJournal of Clinical Oncology, 2011
- Treatment of Multiple Myeloma: A Comprehensive ReviewClinical Lymphoma Myeloma and Leukemia, 2009
- International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple MyelomaLeukemia, 2009
- FDG-positron-emission tomography for staging and therapeutic assessment in patients with plasmacytomaHaematologica, 2008
- Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network studyBMC Cancer, 2006
- Outcomes and patterns of failure in solitary plasmacytoma: A multicenter Rare Cancer Network study of 258 patientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Positron Emission Tomography (PET) for Staging of Solitary PlasmacytomaCancer Biotherapy and Radiopharmaceuticals, 2003
- Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working GroupBritish Journal of Haematology, 2003
- Solitary plasmacytoma of bone and asymptomatic multiple myeloma.2000
- Solitary plasmacytoma of bone: mayo clinic experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989